Tower Research Capital LLC (TRC) - Tenax Therapeutics ownership

Tenax Therapeutics's ticker is and the CUSIP is 88032L506. A total of 18 filers reported holding Tenax Therapeutics in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of Tenax Therapeutics
ValueSharesWeighting
Q4 2023$1,253
-9.9%
4,558
-2.0%
0.00%
Q3 2023$1,391
-0.6%
4,653
-0.3%
0.00%
Q2 2023$1,400
+69900.0%
4,667
-11.7%
0.00%
Q1 2023$25,2840.00%
Other shareholders
Tenax Therapeutics shareholders Q4 2023
NameSharesValueWeighting ↓
Virtu Financial LLC 36,799$110.00%
Allworth Financial LP 1$10.00%
WELLS FARGO & COMPANY/MN 160$480.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Lido Advisors, LLC 10,000$2,9900.00%
Banque Cantonale Vaudoise 50$00.00%
GEODE CAPITAL MANAGEMENT, LLC 118,978$35,0740.00%
TUCKER ASSET MANAGEMENT LLC 2$10.00%
BlackRock Inc. 23,922$7,1530.00%
LPL Financial LLC 20,000$5,9800.00%
View complete list of Tenax Therapeutics shareholders